CN104721791A - Pharmaceutical formulation for treating cardiovascular and cerebrovascular diseases - Google Patents
Pharmaceutical formulation for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN104721791A CN104721791A CN201510148912.8A CN201510148912A CN104721791A CN 104721791 A CN104721791 A CN 104721791A CN 201510148912 A CN201510148912 A CN 201510148912A CN 104721791 A CN104721791 A CN 104721791A
- Authority
- CN
- China
- Prior art keywords
- radix
- juice
- fructus
- cardiovascular
- pharmaceutical formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a pharmaceutical formulation for treating the cardiovascular and cerebrovascular diseases. The pharmaceutical formulation for treating the cardiovascular and cerebrovascular diseases comprises pseudo-ginseng, mongolian snake gourd, poria cocos, safflower, allium macrostemon, immature bitter orange, fructus amomi, salviae miltiorrhizae, American ginseng, dried rehmannia root, bark of eucommia, pulp of dogwood fruit, astragalus, amur corktree, rhizoma anemarrhenae, selfheal, madder, achyranthes root, Chinese angelica, ligusticum wallichii, dried body of ground beetle, pinellia ternate, rhizoma corydalis, bighead atractylodes rhizome, Korean ginseng, lemon juice, ginger juice, garlic juice, roxburgh rose juice and fruit vinegar. Compared with the prior art, the pharmaceutical formulation for treating the cardiovascular and cerebrovascular diseases has no side effect and unique and obvious curative effect and has the effects of warming yang for dispelling cold, removing obstruction of qi and blood circulation and dissipating knot, activating blood and dispersing blood stasis, promoting qi circulation and relieving pain, warming yang and tonifying kidney as well as benefiting qi and nourishing yin, so that the aims of strengthening the body resistance, removing evil and recovering blood flow are achieved, curative ratio is high, most strange flavour can be reduced by virtue of lemon and fruit vinegar when the medicine is taken, and the medicine is easy to take, so that the pharmaceutical formulation for treating the cardiovascular and cerebrovascular diseases has popularization and application values.
Description
Technical field
The present invention relates to a kind of cardiovascular and cerebrovascular diseases medicine, particularly relate to a kind of pharmaceutical formulation for the treatment of cardiovascular and cerebrovascular disease.
Background technology
So-called cardiovascular and cerebrovascular disease is exactly that cardiovascular and cerebrovascular disease are referred to as, and makes a general reference because ischemic or hemorrhage occur for the heart that hyperlipemia, blood are sticky, atherosclerosis, hypertension etc. cause, brain and body tissue.A kind of serious threat mankind, the particularly commonly encountered diseases of more than 50 years old middle-aged and elderly people health, even if apply treatment means most advanced, perfect at present, the cerebrovas-cularaccident survivor of more than 50% still can be had to live can not take care of oneself completely, the number of cardiovascular and cerebrovascular disease is died from every year up to 1,500 ten thousand people in the whole world, occupies the various cause of the death the first.Therefore, control cardiovascular and cerebrovascular disease is the thing that can not despise, and medicine of the prior art all exists various defect, and the medicable Chinese medicine had then swallow by taste strange being difficult to, and Western medicine then side effect is excessive, therefore, needs a kind of new medicine to be born.
Summary of the invention
Object of the present invention is just to provide a kind of pharmaceutical formulation for the treatment of cardiovascular and cerebrovascular disease to solve the problem.
The present invention is achieved through the following technical solutions above-mentioned purpose:
The present invention by under Radix Notoginseng, Fructus Trichosanthis, Poria, Flos Carthami, Bulbus Allii Macrostemonis, Fructus Aurantii Immaturus, Fructus Amomi, Radix Salviae Miltiorrhizae, Radix Panacis Quinquefolii, the Radix Rehmanniae, the Cortex Eucommiae, Fructus Corni, the Radix Astragali, Cortex Phellodendri, the Rhizoma Anemarrhenae, summer mushroom grass, Radix Rubiae, Radix Achyranthis Bidentatae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, eupolyphaga, half, Rhizoma Corydalis, the Rhizoma Atractylodis Macrocephalae, power three, Fructus Citri Limoniae juice, Sucus Zingberis, Bulbus Allii juice, Sucus Rosae Normalis and fruit vinegar form.
As preferably, described Radix Notoginseng 3g, described Fructus Trichosanthis 5g, described Poria 8g, described colored 6g, described Bulbus Allii Macrostemonis 8g, described Fructus Aurantii Immaturus 8g, described Fructus Amomi 12g, described Radix Salviae Miltiorrhizae 7g, described Radix Panacis Quinquefolii 5g, described Radix Rehmanniae 5g, described Cortex Eucommiae 1g, described Fructus Corni 6g, described Radix Astragali 5g, described Cortex Phellodendri 15g, described Rhizoma Anemarrhenae 4g, described summer mushroom grass 1g, described Radix Rubiae 6g, described Radix Achyranthis Bidentatae 2g, described Radix Angelicae Sinensis 7g, described Rhizoma Chuanxiong 3g, described eupolyphaga 8g, described half time 2g, described Rhizoma Corydalis 8g, described Rhizoma Atractylodis Macrocephalae 10g, described power three 10g, described Fructus Citri Limoniae juice 20g, described Sucus Zingberis 2g, described Bulbus Allii juice 2g, described Sucus Rosae Normalis 15g, described fruit vinegar 25g.Described Fructus Citri Limoniae juice can adopt orange juice or orange juice to substitute.
Beneficial effect of the present invention is:
The present invention is a kind of pharmaceutical formulation for the treatment of cardiovascular and cerebrovascular disease, compared with prior art, the present invention is not only free from side effects, special effect shows and can warming YANG to expel cold, a surname's numbness relieving accumulation of pathogens, blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, temperature male wind-supplying kidney, supplementing QI and nourishing YIN thus reach strengthening body resistance and dispelling evil, restoration of blood flow normal object, cure rate high, important strange taste can be reduced by Fructus Citri Limoniae and fruit vinegar etc. when taking, taking convenience, has the value applied.
Detailed description of the invention
The invention will be further described below:
The present invention by under Radix Notoginseng, Fructus Trichosanthis, Poria, Flos Carthami, Bulbus Allii Macrostemonis, Fructus Aurantii Immaturus, Fructus Amomi, Radix Salviae Miltiorrhizae, Radix Panacis Quinquefolii, the Radix Rehmanniae, the Cortex Eucommiae, Fructus Corni, the Radix Astragali, Cortex Phellodendri, the Rhizoma Anemarrhenae, summer mushroom grass, Radix Rubiae, Radix Achyranthis Bidentatae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, eupolyphaga, half, Rhizoma Corydalis, the Rhizoma Atractylodis Macrocephalae, power three, Fructus Citri Limoniae juice, Sucus Zingberis, Bulbus Allii juice, Sucus Rosae Normalis and fruit vinegar form.
As preferably, described Radix Notoginseng 3g, described Fructus Trichosanthis 5g, described Poria 8g, described colored 6g, described Bulbus Allii Macrostemonis 8g, described Fructus Aurantii Immaturus 8g, described Fructus Amomi 12g, described Radix Salviae Miltiorrhizae 7g, described Radix Panacis Quinquefolii 5g, described Radix Rehmanniae 5g, described Cortex Eucommiae 1g, described Fructus Corni 6g, described Radix Astragali 5g, described Cortex Phellodendri 15g, described Rhizoma Anemarrhenae 4g, described summer mushroom grass 1g, described Radix Rubiae 6g, described Radix Achyranthis Bidentatae 2g, described Radix Angelicae Sinensis 7g, described Rhizoma Chuanxiong 3g, described eupolyphaga 8g, described half time 2g, described Rhizoma Corydalis 8g, described Rhizoma Atractylodis Macrocephalae 10g, described power three 10g, described Fructus Citri Limoniae juice 20g, described Sucus Zingberis 2g, described Bulbus Allii juice 2g, described Sucus Rosae Normalis 15g, described fruit vinegar 25g.Described Fructus Citri Limoniae juice can adopt orange juice or orange juice to substitute.
After being taken by weight by above-mentioned formula, put into marmite, the water adding 5 times amount is brewed into 1 times amount and can takes, and adopts take half an hour after meal when taking, 2 times on the one, within 30th, is a course for the treatment of.
More than show and describe ultimate principle of the present invention and principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and description just illustrates principle of the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.
Claims (3)
1. treat a pharmaceutical formulation for cardiovascular and cerebrovascular disease, it is characterized in that: by under Radix Notoginseng, Fructus Trichosanthis, Poria, Flos Carthami, Bulbus Allii Macrostemonis, Fructus Aurantii Immaturus, Fructus Amomi, Radix Salviae Miltiorrhizae, Radix Panacis Quinquefolii, the Radix Rehmanniae, the Cortex Eucommiae, Fructus Corni, the Radix Astragali, Cortex Phellodendri, the Rhizoma Anemarrhenae, summer mushroom grass, Radix Rubiae, Radix Achyranthis Bidentatae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, eupolyphaga, half, Rhizoma Corydalis, the Rhizoma Atractylodis Macrocephalae, power three, Fructus Citri Limoniae juice, Sucus Zingberis, Bulbus Allii juice, Sucus Rosae Normalis and fruit vinegar form.
2. the pharmaceutical formulation for the treatment of cardiovascular and cerebrovascular disease according to claim 1, it is characterized in that: described Radix Notoginseng 3g, described Fructus Trichosanthis 5g, described Poria 8g, described colored 6g, described Bulbus Allii Macrostemonis 8g, described Fructus Aurantii Immaturus 8g, described Fructus Amomi 12g, described Radix Salviae Miltiorrhizae 7g, described Radix Panacis Quinquefolii 5g, described Radix Rehmanniae 5g, described Cortex Eucommiae 1g, described Fructus Corni 6g, described Radix Astragali 5g, described Cortex Phellodendri 15g, described Rhizoma Anemarrhenae 4g, described summer mushroom grass 1g, described Radix Rubiae 6g, described Radix Achyranthis Bidentatae 2g, described Radix Angelicae Sinensis 7g, described Rhizoma Chuanxiong 3g, described eupolyphaga 8g, described half time 2g, described Rhizoma Corydalis 8g, described Rhizoma Atractylodis Macrocephalae 10g, described power three 10g, described Fructus Citri Limoniae juice 20g, described Sucus Zingberis 2g, described Bulbus Allii juice 2g, described Sucus Rosae Normalis 15g, described fruit vinegar 25g.
3. the pharmaceutical formulation for the treatment of cardiovascular and cerebrovascular disease according to claim 1 and 2, is characterized in that: described Fructus Citri Limoniae juice can adopt orange juice or orange juice to substitute.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510148912.8A CN104721791A (en) | 2015-04-01 | 2015-04-01 | Pharmaceutical formulation for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510148912.8A CN104721791A (en) | 2015-04-01 | 2015-04-01 | Pharmaceutical formulation for treating cardiovascular and cerebrovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104721791A true CN104721791A (en) | 2015-06-24 |
Family
ID=53446587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510148912.8A Pending CN104721791A (en) | 2015-04-01 | 2015-04-01 | Pharmaceutical formulation for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104721791A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107812072A (en) * | 2017-10-30 | 2018-03-20 | 李兴杰 | A kind of medicine for treating cardiovascular and cerebrovascular disease |
| CN112717092A (en) * | 2021-01-22 | 2021-04-30 | 行艳丽 | Traditional Chinese medicine for preventing cardiovascular and cerebrovascular diseases and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2304050A (en) * | 1992-11-26 | 1997-03-12 | Eladevi Shah | Herbal compositions |
| CN1891279A (en) * | 2005-07-06 | 2007-01-10 | 陈克治 | Capsule for treating cardio-cerebrovasular disease |
| CN103028017A (en) * | 2011-09-30 | 2013-04-10 | 任正启 | Drug for treatment of cardiovascular and cerebrovascular diseases |
| CN103893499A (en) * | 2012-12-28 | 2014-07-02 | 贾晓萍 | Traditional Chinese medicine and medicine pillow for treatment of cardio-cerebrovascular diseases |
| CN104172330A (en) * | 2014-07-02 | 2014-12-03 | 张树珍 | Health care fruit and vegetable juice good for cardiovascular and cerebrovascular system |
-
2015
- 2015-04-01 CN CN201510148912.8A patent/CN104721791A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2304050A (en) * | 1992-11-26 | 1997-03-12 | Eladevi Shah | Herbal compositions |
| CN1891279A (en) * | 2005-07-06 | 2007-01-10 | 陈克治 | Capsule for treating cardio-cerebrovasular disease |
| CN103028017A (en) * | 2011-09-30 | 2013-04-10 | 任正启 | Drug for treatment of cardiovascular and cerebrovascular diseases |
| CN103893499A (en) * | 2012-12-28 | 2014-07-02 | 贾晓萍 | Traditional Chinese medicine and medicine pillow for treatment of cardio-cerebrovascular diseases |
| CN104172330A (en) * | 2014-07-02 | 2014-12-03 | 张树珍 | Health care fruit and vegetable juice good for cardiovascular and cerebrovascular system |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107812072A (en) * | 2017-10-30 | 2018-03-20 | 李兴杰 | A kind of medicine for treating cardiovascular and cerebrovascular disease |
| CN112717092A (en) * | 2021-01-22 | 2021-04-30 | 行艳丽 | Traditional Chinese medicine for preventing cardiovascular and cerebrovascular diseases and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103083539B (en) | Chinese herbal compound for treating common respiratory system diseases | |
| CN103041285A (en) | Cerebral apoplexy commemorative sign treatment method by utilizing Chinese medicaments | |
| CN101884761A (en) | Medicament for treating cirrhosis and portal hypertension | |
| CN1136444A (en) | Medicine for curing coronary heart disease | |
| CN104721791A (en) | Pharmaceutical formulation for treating cardiovascular and cerebrovascular diseases | |
| CN104547785A (en) | Traditional Chinese medicine for treating hepatitis | |
| CN105395688A (en) | Traditional Chinese medicine for obstetrics and gynecology postpartum recovery and preparation method thereof | |
| CN104740131A (en) | Traditional Chinese medicinal oral liquid for treating apoplexy hemiplegia | |
| CN104707089A (en) | Coronary heart disease treating traditional Chinese medicine formula | |
| CN103446535B (en) | A kind of Miao Ethnomedicine for the treatment of coronary heart disease | |
| CN106109968A (en) | Rhizoma Gastrodiae, Radix Polygoni Multiflori Preparata pharmaceutical composition and preparation method thereof | |
| CN101757254A (en) | Traditional Chinese medicine preparation for preventing and curing postpartum alopecia | |
| CN104721530A (en) | Antihypertensive traditional Chinese medicine composition | |
| CN104056222A (en) | Menstruation-regulating beauty tonic pill | |
| CN104547881A (en) | Traditional Chinese medicine for reducing blood lipids | |
| CN103877369A (en) | Hepatitis B treatment compound | |
| CN105031578A (en) | Medicament for treating myocarditis | |
| CN1628724A (en) | Medicine for promoting blood circulation and dredging collaterals | |
| CN106237241A (en) | A kind of herbal composite that can be used for treating apoplexy | |
| CN105456821A (en) | Oral traditional Chinese medicine for treating eczema and preparation method thereof | |
| CN104436068A (en) | Traditional Chinese medicinal composition for treating cerebral infarction | |
| CN104922479A (en) | Traditional Chinese medicinal preparation for treating cerebrovascular disease | |
| CN104288689A (en) | Traditional Chinese medicine for treating mucocutaneous lymph node syndromes and preparation method of traditional Chinese medicine | |
| CN104771721A (en) | Drug formula for treating upper respiratory infection | |
| CN104524274A (en) | Traditional Chinese medicine for treatment of cardio-cerebrovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150624 |
|
| WD01 | Invention patent application deemed withdrawn after publication |